Efficacy, safety and tolerability of growth hormone in patients with amyotrophic lateral sclerosis as add-on therapy to riluzole.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2012
At a glance
- Drugs Somatrogon (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 16 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
- 15 Apr 2011 Identifiers FARM53XBKT and RF-SDN2007-666932 added
- 26 May 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History